Q2 2013 Holdings
Filed 2013-08-14 | 11 holdings | $9.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam(ALNY) | Common | 02043Q107 | $9.7M | 313,053 | 98.8% |
| Amarin | SPONS ADR | 023111206 | $46.8K | 8,087,486 | 0.5% |
| Portola | Common | 737010108 | $30.5K | 1,240,917 | 0.3% |
| Supernus(SUPN) | Common | 868459108 | $23.2K | 3,600,000 | 0.2% |
| Oncogenex Pharma | Common | 68230A106 | $5.9K | 603,740 | 0.1% |
| Cempra | Common | 15130J109 | $5.6K | 714,285 | 0.1% |
| Zogenix | Common | 98978L105 | $4.0K | 2,335,218 | 0.0% |
| Anthera | Common | 03674U102 | $1.7K | 3,503,956 | 0.0% |
| Hyperion | Common | 44915N101 | $1.4K | 62,500 | 0.0% |
| GW Pharma (US) | ADS | 36197T103 | $879 | 102,200 | 0.0% |
| Zalicus | Common | 98887C105 | $268 | 473,800 | 0.0% |